SUBSCRIBE
SUBSCRIBE
News   Business

Ariad Pharmaceuticals, Inc. Q2 Loss Narrower Than Expected; COO Resigns

August 7, 2008 | 
1 min read

Aug 7 (Reuters) - Ariad Pharmaceuticals Inc posted a narrower-than-expected quarterly loss, helped by milestone payments from its partner Merck & Co Inc, and said its chief operating officer resigned.

Earnings
MORE ON THIS TOPIC
Illustration of two arrows merging into one
Mergers & acquisitions
Troubled Drugmakers Mallinckrodt, Endo Officially Announce $6.7B Merger
March 13, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: Merck building and sign in Silicon Valley
Vaccines
Good Day for Gardasil as Merck Wins Safety Suit, Drops $1B for Manufacturing Push
March 12, 2025
 · 
2 min read
 · 
Tristan Manalac
Concept of money prize. Vector illustration. Halftone hand holds bouquet of money flowers. Gift prize, donation, earnings, bonus or cashback concept. Retro poster or banner. Creative trend collage.
Weight loss
Roche Makes Another Obesity Play With Potential $5.3B Amylin Pact With Zealand
March 12, 2025
 · 
2 min read
 · 
Tristan Manalac
A contemporary artistic collage depicting a hand holding pills, passing them to another hand. The concept of medication and treatment.
Collaboration
Ionis Sends Polycythemia Vera Drug to Ono in Licensing Deal Worth Nearly $1B Biobucks
March 12, 2025
 · 
2 min read
 · 
Tristan Manalac